Page last updated: 2024-08-17

cycloserine and amikacin

cycloserine has been researched along with amikacin in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19902 (8.33)18.7374
1990's1 (4.17)18.2507
2000's4 (16.67)29.6817
2010's15 (62.50)24.3611
2020's2 (8.33)2.80

Authors

AuthorsStudies
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S1
Khanna, A; Pareek, PK; Raj, VS; Rattan, A; Saini, KS; Sharma, P; Singh, H; Sood, R; Tarai, B; Upadhyay, DJ1
Ali, MA; Choon, TS; Ismail, R; Kumar, RS; Wei, AC; Yoon, YK1
Danac, R; Mangalagiu, II1
Asís, SE; Buldain, GY; Muscia, GC1
Ali, MA; Choon, TS; Kanchithalaivan, S; Ponnuchamy, S; Ranjith Kumar, R1
Ashraf Ali, M; Choon, TS; Devi Bala, B; Muthusaravanan, S; Perumal, S1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Moreno-Viguri, E; Pérez-Silanes, S; Santivañez-Veliz, M; Torres, E1
Ashraf Ali, M; Bharkavi, C; Muthusubramanian, S; Osman, H; Perumal, S; Vivek Kumar, S2
Baikova, IP; Giniyatullina, GV; Kataev, VE; Kazakova, OB; Lopatina, TV; Medvedeva, NI; Smirnova, IE1
da Silva Emery, F; de Melo, SMG; Fumagalli, F; Pavan, FR; Ribeiro, CM; Solcia, MC1
Barrio, JL; Pitchenik, AE; Rodriguez, JL1
Baird, B; Fauci, AS; Gill, V; Grimes, G; Lane, HC; Masur, H; Tuazon, C1
Furukawa, T; Komachi, H; Nagai, R; Saito, Y; Takewaki, S; Uchihara, T1
Kam, KM; Yip, CW1
Chimara, E; da Silva Telles, MA; Ferrazoli, L; Riley, LW1
Farnia, P; Khoshnood, K; Mansoori, SD; Masjedi, H; Masjedi, MR; Mirsaeidi, SM; Mohammadi, F; Pooramiri, MV; Rowhani-Rahbar, A; Tabarsi, P; Velayati, AA; Zahirifard, S1
Amiri, M; Baghaei, P; Caminero, JA; Chitsaz, E; Farnia, P; Kazempour, M; Mansouri, D; Marjani, M; Masjedi, MR; Shamaei, M; Tabarsi, P; Velayati, AA1
Gratz, J; Heysell, SK; Houpt, ER; Kibiki, GS; Kumburu, H; Mpagama, SG; Ndusilo, N; Peloquin, CA; Stroup, S1
Chen, ST; Huang, HR; Jiang, GL; Ma, YF; Wang, GR; Yu, X1
Basdeo, SA; Cahill, C; Cox, DJ; Gogan, KM; Gordon, SV; Keane, J; O'Connell, F; O'Sullivan, J; Phelan, JJ1
Guo, Y; Liu, H; Sha, W; Shen, H; Shen, X; Tan, G; Wu, X; Wu, Z; Yang, J; Yu, F1

Reviews

1 review(s) available for cycloserine and amikacin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for cycloserine and amikacin

ArticleYear
Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2005, Volume: 9, Issue:6

    Topics: Adolescent; Adult; Aged; Amikacin; Antitubercular Agents; Cycloserine; Drug Therapy, Combination; Female; Humans; Iran; Isoniazid; Male; Middle Aged; Ofloxacin; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2005

Other Studies

22 other study(ies) available for cycloserine and amikacin

ArticleYear
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4

    Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen

2007
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; DNA Mutational Analysis; DNA-Directed RNA Polymerases; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; India; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Point Mutation; Polymerase Chain Reaction; Rifampin

2010
A facile three-component [3+2]-cycloaddition for the regioselective synthesis of highly functionalised dispiropyrrolidines acting as antimycobacterial agents.
    Bioorganic & medicinal chemistry letters, 2013, Mar-01, Volume: 23, Issue:5

    Topics: Anti-Bacterial Agents; Cycloaddition Reaction; High-Throughput Screening Assays; Microbial Sensitivity Tests; Pyrrolidines

2013
Antimycobacterial activity of nitrogen heterocycles derivatives: bipyridine derivatives. Part III.
    European journal of medicinal chemistry, 2014, Mar-03, Volume: 74

    Topics: Antitubercular Agents; Heterocyclic Compounds; Magnetic Resonance Spectroscopy; Models, Molecular; Nitrogen; Pyridines

2014
Design, synthesis and evaluation of acridine and fused-quinoline derivatives as potential anti-tuberculosis agents.
    European journal of medicinal chemistry, 2014, Feb-12, Volume: 73

    Topics: Acridines; Animals; Antitubercular Agents; Cell Line; Cyclization; Drug Design; Drug Evaluation, Preclinical; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinolines

2014
Antimycobacterial evaluation of novel hybrid arylidene thiazolidine-2,4-diones.
    Bioorganic & medicinal chemistry letters, 2014, Feb-15, Volume: 24, Issue:4

    Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazolidinediones

2014
Sequential synthesis of amino-1,4-naphthoquinone-appended triazoles and triazole-chromene hybrids and their antimycobacterial evaluation.
    European journal of medicinal chemistry, 2014, Oct-06, Volume: 85

    Topics: Antitubercular Agents; Benzopyrans; Chemistry Techniques, Synthetic; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Naphthoquinones; Triazoles

2014
Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis.
    Bioorganic & medicinal chemistry letters, 2016, May-01, Volume: 26, Issue:9

    Topics: Animals; Antitubercular Agents; Cell Line; Cyclic N-Oxides; Drug Resistance, Multiple, Bacterial; Latent Tuberculosis; Mice; Mycobacterium tuberculosis; Quinoxalines; Tuberculosis, Multidrug-Resistant

2016
A facile stereoselective synthesis of dispiro-indeno pyrrolidine/pyrrolothiazole-thiochroman hybrids and evaluation of their antimycobacterial, anticancer and AchE inhibitory activities.
    Bioorganic & medicinal chemistry, 2016, 11-15, Volume: 24, Issue:22

    Topics: Acetylcholinesterase; Anti-Bacterial Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholinesterase Inhibitors; Chromones; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Indenes; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Spiro Compounds; Stereoisomerism; Structure-Activity Relationship; Thiazoles

2016
One-pot microwave assisted stereoselective synthesis of novel dihydro-2'H-spiro[indene-2,1'-pyrrolo-[3,4-c]pyrrole]-tetraones and evaluation of their antimycobacterial activity and inhibition of AChE.
    Bioorganic & medicinal chemistry letters, 2017, 07-15, Volume: 27, Issue:14

    Topics: Acetylcholinesterase; Antitubercular Agents; Cholinesterase Inhibitors; Crystallography, X-Ray; Drug Design; Enzyme Activation; Inhibitory Concentration 50; Microbial Sensitivity Tests; Microwaves; Molecular Conformation; Mycobacterium tuberculosis; Pyrroles; Stereoisomerism; Structure-Activity Relationship

2017
Synthesis and antimycobacterial activity of triterpeni≿ A-ring azepanes.
    European journal of medicinal chemistry, 2018, Jan-01, Volume: 143

    Topics: Antitubercular Agents; Azepines; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triterpenes

2018
Exploiting the furo[2,3-b]pyridine core against multidrug-resistant Mycobacterium tuberculosis.
    Bioorganic & medicinal chemistry letters, 2019, 04-15, Volume: 29, Issue:8

    Topics: Amination; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Furans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyridines; Structure-Activity Relationship

2019
Pulmonary nocardiosis in the acquired immunodeficiency syndrome. Diagnosis with bronchoalveolar lavage and treatment with non-sulphur containing drugs.
    Chest, 1986, Volume: 90, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Cycloserine; Drug Therapy, Combination; Humans; Male; Minocycline; Nocardia asteroides; Nocardia Infections; Pneumonia, Pneumocystis; Pulmonary Alveoli; Radiography; Respiratory Tract Infections; Therapeutic Irrigation

1986
Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
    The Journal of infectious diseases, 1987, Volume: 155, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clofazimine; Cycloserine; Drug Therapy, Combination; Humans; Isoniazid; Lactams, Macrocyclic; Mycobacterium avium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Sepsis

1987
Successful treatment of atypical mycobacterial meningitis by fluoroquinolone.
    Journal of the neurological sciences, 1996, Volume: 143, Issue:1-2

    Topics: Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cycloserine; Ethambutol; Humans; Injections, Spinal; Isoniazid; Male; Meningitis; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Ofloxacin; Polymerase Chain Reaction; Rifampin; Streptomycin

1996
Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2004, Volume: 8, Issue:6

    Topics: Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Communicable Disease Control; Cycloserine; Directly Observed Therapy; Drug Combinations; Ethionamide; Hong Kong; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Population Surveillance; Program Evaluation; Recurrence; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2004
Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates.
    Journal of medical microbiology, 2005, Volume: 54, Issue:Pt 10

    Topics: Amikacin; Anti-Bacterial Agents; Brazil; Ciprofloxacin; Clarithromycin; Clofazimine; Cycloserine; DNA Fingerprinting; DNA, Bacterial; Doxycycline; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rifabutin; Rifampin; Streptomycin

2005
Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran.
    Microbial drug resistance (Larchmont, N.Y.), 2010, Volume: 16, Issue:1

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Clinical Protocols; Cycloserine; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Iran; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Prothionamide; Treatment Outcome; Tuberculosis, Pulmonary

2010
Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2

    Topics: Adolescent; Adult; Amikacin; Antitubercular Agents; Cycloserine; Ethionamide; Female; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Sputum; Tanzania; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2014
Sensititre® MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2016, Volume: 20, Issue:3

    Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Ethambutol; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis

2016
The Iron Chelator Desferrioxamine Increases the Efficacy of Bedaquiline in Primary Human Macrophages Infected with BCG.
    International journal of molecular sciences, 2021, Mar-13, Volume: 22, Issue:6

    Topics: Amikacin; Antitubercular Agents; Bacterial Load; Cell Survival; Clofazimine; Cycloserine; Deferoxamine; Diarylquinolines; Drug Resistance, Bacterial; Drug Synergism; Gene Expression; Humans; Interferon-gamma; Interleukin-1beta; Interleukin-6; Iron; Iron Chelating Agents; Linezolid; Macrophages; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium bovis; Primary Cell Culture; Pyrazinamide

2021
Use of Whole-Genome Sequencing to Predict
    Microbiology spectrum, 2022, 04-27, Volume: 10, Issue:2

    Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Drug Resistance; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant

2022